Olanzapine

Product NDC
67184-0573
11-digit product format
671840573
Labeler code
67184
Product ID
67184-0573_816c3bbf-aa02-47e2-88d2-3a50c7764a84
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Olanzapine
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR
Labeler
Qilu Pharmaceutical Co., Ltd.
Application
ANDA218116
Marketing category
ANDA
Marketing start
2025-11-11
Substance
OLANZAPINE
Active strength
10 mg/2mL
Pharmacologic classes
Atypical Antipsychotic [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A218116-001OLANZAPINEOLANZAPINE10MG/VIALPOWDER / INTRAMUSCULARAP2025-05-16

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A218116-001AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A218116-001OLANZAPINE10MG/VIALPOWDER / INTRAMUSCULARAP2025-05-16011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A218116-001OLANZAPINE10MG/VIALINJECTABLE / INTRAMUSCULARAP2025-05-1631067a03dcf5…
2025-08-23 18:47 UTC2025-08A218116-001OLANZAPINE10MG/VIALINJECTABLE / INTRAMUSCULARAP2025-05-166a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218116-001OLANZAPINE10MG/VIALPOWDER / INTRAMUSCULARAP2025-05-16a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A218116-001AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A218116-001AP131067a03dcf5…
2025-08-23 18:47 UTC2025-08A218116-001AP16a471c1ec25d…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A218116-001AP1a50c72e98297…

Additional Listing Data#

Finished product
Yes
Brand name base
Olanzapine
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
OLANZAPINE10 mg/2mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
N7U69T4SZRInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
485968Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
12ce860a-6f22-4db6-8acf-786b40f5a5a5Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
42e9462d-db65-453b-8069-8fb2df9182e8Product name120211216
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
12d02c27-e8da-47f1-b815-ccca982731efProduct name920170802
877783eb-030c-6e3f-0979-804cf94d8856Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
67184-0573-1Olanzapine2 mL in 1 VIALINJECTION, POWDER, FOR SOLUTION21
67184-0573-1Olanzapine1 in 1 CARTONINJECTION, POWDER, FOR SOLUTION11

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OlanzapineOLANZAPINEHikma Pharmaceuticals USA Inc.63bcfe98-d1fc-4cd7-9212-f59ee4dcc6d12026-06-03Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 218116
application number: ANDA218116
OlanzapineOLANZAPINEQilu Pharmaceutical Co., Ltd.12ce860a-6f22-4db6-8acf-786b40f5a5a52025-10-30Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 218116
application number: ANDA218116
ndc (product): 67184-0573

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
485968OLANZapine 10 MG InjectionPSN12ce860a-6f22-4db6-8acf-786b40f5a5a51
485968olanzapine 10 MG InjectionSCD12ce860a-6f22-4db6-8acf-786b40f5a5a51

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startSampleExclude flagStatus
67184-0573-1671840573011 VIAL in 1 CARTON (67184-0573-1) / 2 mL in 1 VIAL1 vial2025-11-11NoNoCurrent